SFPG
TNDM icon

Stonebridge Financial Planning Group’s Tandem Diabetes Care TNDM Stock Holding History

Stonebridge Financial Planning Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-48
Closed -$5K – 343
2021
Q4 		$5K Hold
48
– – ﹤0.01% 375
2021
Q3 		$7K Hold
48
– – ﹤0.01% 369
2021
Q2 		$5K Hold
48
– – ﹤0.01% 384
2021
Q1 		$4K Hold
48
– – ﹤0.01% 399
2020
Q4 		$5K Hold
48
– – ﹤0.01% 365
2020
Q3 		$6K Sell
48
-47
-49% -$4.94K ﹤0.01% 346
2020
Q2 		$9K Hold
95
– – 0.01% 325
2020
Q1 		$6K Hold
95
– – 0.01% 344
2019
Q4 		$6K Buy
+95
New +$5.86K 0.01% 321

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Stonebridge Financial Planning Group's TNDM Position: Q1 2022 in Review

Stonebridge Financial Planning Group sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 48 shares — an estimated $5K sold.

Stonebridge Financial Planning Group first reported a position in TNDM in Q4 2019 and held it in 9 quarters. The position peaked at $9K in Q2 2020. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Stonebridge Financial Planning Group reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • Stonebridge Financial Planning Group sold 48 Tandem Diabetes Care shares in Q1 2022, an estimated $5K.
  • Stonebridge Financial Planning Group first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 9 quarters.
  • Stonebridge Financial Planning Group's Tandem Diabetes Care position peaked at $9K in Q2 2020.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Stonebridge Financial Planning Group's 13F filing for Q1 2022, filed 10 May 2022.